biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Knock at The Door

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 18, 2023 3:41pm

160 Views

Post# 35455172

RE:Knock at The Door

In my previous post I revealed that my wife and I are going through bankruptcy proceedings. It will be public knowledge, I believe, in a couple of weeks. My statement about it was worded in a way that some people are thinking meant that Bioasis is going bankrupt. I have no knowledge of that and was speaking only about my own situation.

Also, I apologize for the typos in that post. Ugly ones. Too early in the morning, I think, no coffee yet, my keyboard battery was low, I'm getting older, a little hung over, the air is thick with forest fire smoke, etc etc.

jd

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload